Author:
Rago A.,Palumbo G.,Tordi A.,Bianchi S.,Offidani M.,di Toritto T. Caravita
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference9 articles.
1. Bringhen S, Milan A, Ferri C, Wäsch R, Gay F, Larocca A et al (2016) European Hematology Association, the European Myeloma Network and the Italian Society of Arterial Hypertension Cardiovascular adverse events in modern myeloma therapy - incidence and risks. A review from the European Myeloma Network (EMN) and Italian Society of Arterial Hypertension (SIIA). Hematologica 9:1422–1432
2. Kazandjian D (2016) Multiple myeloma epidemiology and survival: a unique malignancy. Semin Oncol 6:676–681
3. Szalat R, Munshi NC (2019) Novel agents in multiple myeloma. Cancer J 1:45–53
4. Linari S, Castaman G (2016) Hematological manifestations and complications of Gaucher disease. Expert Rev Hematol 9:51–58
5. Shiran A, Brenner B, Laor A, Tatarsky I (1993) Increased risk of cancer in patients with Gaucher disease. Cancer 72:219–224